Chikungunya virus: Difference between revisions
From IDWiki
(ββ) |
(ββ) Β |
||
| Line 16: | Line 16: | ||
*Incubation period of [[Usual incubation period::1 to 12 days]] |
*Incubation period of [[Usual incubation period::1 to 12 days]] |
||
*[[Causes::Fever]], [[Causes::rash]], and [[Causes::arthralgias]] |
*[[Causes::Fever]], [[Causes::rash]], and [[Causes::arthralgias]] |
||
*Fever may be "saddleback", with remittance at 4 to 8 days followed by recrudescence for 2 weeks |
**Fever may be "saddleback", with remittance at 4 to 8 days followed by recrudescence for 2 weeks |
||
*Arthritis is typically a symmetrical polyarticular arthritis that involves small joints and knees |
**Arthritis is typically a symmetrical polyarticular arthritis that involves small joints and knees |
||
**Resolves over months to a year (sometimes longer), but arthralgias (Β± arthritis) can persist for years |
***Resolves over months to a year (sometimes longer), but arthralgias (Β± arthritis) can persist for years |
||
*Rash is macular or maculopapular, and more often central but can involve palms and soles |
**Rash is macular or maculopapular, and more often central but can involve palms and soles |
||
*Other common symptoms include headache, fatigue, nausea, vomiting, and conjunctivitis |
*Other common symptoms include headache, fatigue, nausea, vomiting, and conjunctivitis |
||
*Bloodwork shows leukopenia, thrombocytopenia, hypocalcemia, and mild to moderate transaminase elevation |
*Bloodwork shows leukopenia, thrombocytopenia, hypocalcemia, and mild to moderate transaminase elevation |
||
*Children are more likely to develop neurological symptoms (status epilepticus, complex seizures, and encephalitis) and dermatologic symptoms (bullous rash) |
*Children are more likely to develop neurological symptoms (status epilepticus, complex seizures, and encephalitis) and dermatologic symptoms (bullous rash) |
||
== |
==Differential Diagnosis== |
||
{| class="wikitable" |
{| class="wikitable" |
||
!Feature |
!Feature |
||
Latest revision as of 18:13, 22 August 2020
Background
Microbiology
- Member of the Alphavirus genus within the Togaviridae family
- Closely related to oβnyong-nyong virus
- Four genotypes: East-Central-South African, West African, Indian Ocean, and Asian
Epidemiology
- The primary vectors are Aedes aegypti and Aedes albopictus mosquitoes
- Endemic in most of Africa, Southeast Asia, the Philippines, and South and Central America
- There has been autochthonous transmission in Italy and Frace
Clinical Manifestations
- Incubation period of 1 to 12 days
- Fever, rash, and arthralgias
- Fever may be "saddleback", with remittance at 4 to 8 days followed by recrudescence for 2 weeks
- Arthritis is typically a symmetrical polyarticular arthritis that involves small joints and knees
- Resolves over months to a year (sometimes longer), but arthralgias (Β± arthritis) can persist for years
- Rash is macular or maculopapular, and more often central but can involve palms and soles
- Other common symptoms include headache, fatigue, nausea, vomiting, and conjunctivitis
- Bloodwork shows leukopenia, thrombocytopenia, hypocalcemia, and mild to moderate transaminase elevation
- Children are more likely to develop neurological symptoms (status epilepticus, complex seizures, and encephalitis) and dermatologic symptoms (bullous rash)
Differential Diagnosis
| Feature | Dengue | Zika | Chikungunya |
|---|---|---|---|
| Asymptomatic | 40-80% | 35-85% | 3-28% |
| Fever | +++ | ++ | +++ |
| Rash | + | +++ | ++ |
| Conjunctivitis | β | ++ | + |
| Arthralgia | + | ++ | +++ |
| Myalgia | ++ | + | + |
| Headache | ++ | + | ++ |
| Hemorrhage | ++ | β | β |
| Shock | + | β | β |
| Thrombocytopenia | +++ | + | β |
| Leukopenia | ++ | β | ++ |
Management
- High-dose NSAIDs
- May need aggressive rheumatologic medications for arthritis
- Supportive treatment
Prognosis
- 12% risk of chronic arthralgias up to 3 years post-infection
- Neonates and elderly at highest risk for neurological sequelae
